胆固醇检测市场规模、份额及成长分析（按产品、检测、年龄层、应用、分销管道和地区）- 产业预测，2025-2032 年

2023 年全球胆固醇检测市场规模价值为 73.7 亿美元，预计将从 2024 年的 79.9 亿美元成长到 2032 年的 152.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.4%。

胆固醇检测市场呈上升趋势，主要是由于生活方式相关疾病的增加以及久坐生活方式和肥胖导致的心血管疾病的盛行率增加。定期筛检和检查，以及非处方检测套组和小型电子设备的便利性等技术进步进一步推动了需求。此外，人口老化导致高胆固醇和相关疾病的风险更高，这也大大促进了市场扩张。在医疗保健倡议和教育宣传活动的支持下，公众对预防性医疗保健的认识不断提高，正在推动常规胆固醇监测。但挑战包括诊断实验室的短缺、监管障碍以及发展中地区缺乏熟练的专业人员。儘管有这些限制，但透过医疗保健投资和技术创新，机会仍在不断涌现，从而形成了充满活力的市场格局。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 宏观经济指标
• 价值链分析
• 定价分析

胆固醇检测市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 检测套组
• 试纸
• 其他的

胆固醇测试市场规模（按测试和复合年增长率） (2025-2032)

• 市场概况
• 总胆固醇检测
• 高密度脂蛋白（HDL）胆固醇检测
• 低密度脂蛋白（LDL）胆固醇检测
• 三酸甘油酯测试
• 其他的

胆固醇检测市场规模（依年龄层划分）及复合年增长率（2025-2032）

• 市场概况
• 老年人
• 成人
• 孩子们

胆固醇测试市场规模（按应用划分）及复合年增长率（2025-2032）

• 市场概况
• 心血管疾病
• 糖尿病
• 肥胖
• 高血脂症
• 其他的

胆固醇测试市场规模（按分销管道和复合年增长率） (2025-2032)

• 市场概况
• 在商店
• 处方笺

胆固醇检测市场规模（依服务供应商划分）及复合年增长率（2025-2032）

• 市场概况
• 医院和诊所
• 诊断实验室
• 门诊治疗中心
• 其他的

胆固醇检测市场规模（按地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Abbott Laboratories（USA）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Siemens Healthineers AG（Germany）
• Thermo Fisher Scientific Inc.（USA）
• Danaher Corporation（USA）
• PerkinElmer, Inc.（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Randox Laboratories Ltd.（UK）
• Eurofins Scientific（Luxembourg）
• Novartis AG（Switzerland）
• Merck KGaA（Germany）
• Beckman Coulter Inc.（USA）
• Boston Heart Diagnostics Corporation（USA）
• Quest Diagnostics Incorporated（USA）
• Laboratory Corporation of America Holdings（Labcorp）（USA）
• QuidelOrtho Corporation（USA）
• Helena Laboratories Corporation（USA）
• Sekisui Chemical Co., Ltd.（Japan）
• Sinocare Inc.（China）

结论和建议

Global Cholesterol Test Market size was valued at USD 7.37 billion in 2023 and is poised to grow from USD 7.99 billion in 2024 to USD 15.23 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The cholesterol testing market is on an upward trajectory, primarily fueled by rising lifestyle-related diseases and the growing prevalence of cardiovascular disorders due to sedentary habits and obesity. Regular screenings and checkups, alongside the convenience of over-the-counter test kits and technological advancements like miniaturized electronics, are further propelling demand. Additionally, the aging population, which faces higher risks of high cholesterol and related conditions, significantly contributes to market expansion. Increased public awareness of preventive healthcare, supported by healthcare initiatives and educational campaigns, drives routine cholesterol monitoring. However, challenges such as a lack of diagnostic labs, regulatory hurdles, and the shortage of skilled professionals in developing regions exist. Despite these constraints, opportunities arise through healthcare investments and technological innovation, promising a dynamic market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cholesterol Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cholesterol Test Market Segmental Analysis

Global Cholesterol Test Market is segmented by Product, Test, Age Group, Application, Distribution Channel, Service Provider and region. Based on Product, the market is segmented into Testing Kits, Testing Strips and Others. Based on Test, the market is segmented into Total Cholesterol Tests, High Density Lipoprotein (HDL) Cholesterol Tests, Low Density Lipoprotein (LDL) Cholesterol Tests, Triglyceride Tests and Others. Based on Age Group, the market is segmented into Geriatric, Adult and Pediatric. Based on Application, the market is segmented into Cardiovascular Diseases, Diabetes, Obesity, Hyperlipidemia and Others. Based on Distribution Channel, the market is segmented into Over the Counter and Prescription Based. Based on Service Provider, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Ambulatory Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cholesterol Test Market

The global cholesterol test market is significantly influenced by the rising prevalence of cardiovascular diseases, such as heart disease and stroke, which continue to be the primary contributors to global morbidity and mortality rates. As awareness of the link between cholesterol levels and cardiovascular health increases, the necessity for cholesterol testing as a critical component of risk assessment profoundly enhances the demand for various cholesterol testing products and services. This growing emphasis on preventive healthcare and early detection plays a vital role in the expansion of the cholesterol testing market, motivating individuals and healthcare professionals to prioritize regular testing in their health management strategies.

Restraints in the Global Cholesterol Test Market

One of the major constraints affecting the Global Cholesterol Test market is the financial burden associated with cholesterol testing. In areas with inadequate healthcare infrastructure or for individuals without insurance, the expense of these tests can be prohibitive. This high cost may discourage many patients, particularly those from lower socioeconomic backgrounds, from seeking regular cholesterol screenings. Consequently, this limitation can hinder the overall market growth and accessibility of necessary health evaluations, resulting in untreated cardiovascular issues and related health complications in populations that are already vulnerable. Addressing these cost barriers is crucial for enhancing screening rates and improving public health outcomes.

Market Trends of the Global Cholesterol Test Market

The Global Cholesterol Test market is experiencing a significant transformation driven by advancements in testing technologies. Emerging innovations like point-of-care devices, non-invasive methods, and high-sensitivity assays are leading to more accurate, efficient, and accessible cholesterol assessments. Additionally, the integration of cholesterol testing with digital health solutions, electronic health records (EHRs), and telemedicine platforms is enhancing the landscape, facilitating remote monitoring and improved patient engagement. This convergence not only streamlines data management but also optimizes cholesterol management strategies across diverse healthcare settings, positioning the market for robust growth as healthcare increasingly embraces technology-driven solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cholesterol Test Market Size by Product & CAGR (2025-2032)

• Market Overview
• Testing Kits
• Testing Strips
• Others

Global Cholesterol Test Market Size by Test & CAGR (2025-2032)

• Market Overview
• Total Cholesterol Tests
• High Density Lipoprotein (HDL) Cholesterol Tests
• Low Density Lipoprotein (LDL) Cholesterol Tests
• Triglyceride Tests
• Others

Global Cholesterol Test Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Geriatric
• Adult
• Pediatric

Global Cholesterol Test Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cardiovascular Diseases
• Diabetes
• Obesity
• Hyperlipidemia
• Others

Global Cholesterol Test Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Over the Counter
• Prescription Based

Global Cholesterol Test Market Size by Service Provider & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Diagnostic Laboratories
• Ambulatory Care Centers
• Others

Global Cholesterol Test Market Size & CAGR (2025-2032)

• North America (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
  • US
  • Canada
• Europe (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Test, Age Group, Application, Distribution Channel, Service Provider)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Heart Diagnostics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (Labcorp) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Chemical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinocare Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations